Atlas Capital Advisors’s Companhia Brasileira de Distribuicao CBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,356
Closed -$7.3K 969
2022
Q4
$7.3K Hold
2,356
﹤0.01% 760
2022
Q3
$8.34K Hold
2,356
﹤0.01% 733
2022
Q2
$7.3K Sell
2,356
-8,423
-78% -$35.7K ﹤0.01% 789
2022
Q1
$54.3K Buy
10,779
+9,671
+873% +$41K 0.01% 534
2021
Q4
$4.42K Sell
1,108
-1,058
-49% -$4.6K ﹤0.01% 803
2021
Q3
$10.2K Hold
2,166
﹤0.01% 721
2021
Q2
$16.9K Buy
2,166
+1,058
+95% +$7.57K ﹤0.01% 671
2021
Q1
$6.45K Hold
1,108
﹤0.01% 733
2020
Q4
$15.9K Buy
+1,108
New +$14.2K ﹤0.01% 562
2020
Q3
Sell
-1,108
Closed -$14.5K 619
2020
Q2
$14.5K Buy
+1,108
New +$13.4K ﹤0.01% 580
2019
Q4
Sell
-10,039
Closed -$193K 682
2019
Q3
$193K Buy
10,039
+7,088
+240% +$158K 0.06% 323
2019
Q2
$72.2K Hold
2,951
0.02% 438
2019
Q1
$68.7K Buy
2,951
+535
+22% +$13.1K 0.02% 395
2018
Q4
$50.2K Buy
+2,416
New +$51.6K 0.02% 404

Other funds holding CBD

Atlas Capital Advisors's CBD Position: Q1 2023 in Review

Atlas Capital Advisors sold out of Companhia Brasileira de Distribuicao (CBD) in Q1 2023, closing a stake of 2,356 shares — an estimated $7.3K sold.

Atlas Capital Advisors first reported a position in CBD in Q4 2018 and held it in 14 quarters. The position peaked at $193K in Q3 2019. 62 funds tracked by Wall St. Rank hold CBD as of Q1 2023.

  • Atlas Capital Advisors reported no remaining Companhia Brasileira de Distribuicao position as of Q1 2023 after selling out during the quarter.
  • Atlas Capital Advisors sold 2,356 Companhia Brasileira de Distribuicao shares in Q1 2023, an estimated $7.3K.
  • Atlas Capital Advisors first reported a position in Companhia Brasileira de Distribuicao in Q4 2018 and held it in 14 quarters.
  • Atlas Capital Advisors's Companhia Brasileira de Distribuicao position peaked at $193K in Q3 2019.
  • 62 funds tracked by Wall St. Rank held Companhia Brasileira de Distribuicao as of Q1 2023.

Based on Atlas Capital Advisors's 13F filing for Q1 2023, filed 16 May 2023.